Inactivation of Drosophila Huntingtin affects long-term adult functioning and the pathogenesis of a Huntington's disease model

被引:71
|
作者
Zhang, Sheng [5 ]
Feany, Mel B. [1 ]
Saraswati, Sudipta [3 ,4 ]
Littleton, J. Troy [3 ,4 ]
Perrimon, Norbert [2 ,5 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA
[3] MIT, Picower Inst Learning & Memory, Dept Biol, Cambridge, MA 02139 USA
[4] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA
[5] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Genet, Boston, MA 02115 USA
关键词
AXONAL-TRANSPORT; INTERACTING PROTEIN; SYNAPTIC GROWTH; NEURODEGENERATIVE DISEASES; TARGETED DISRUPTION; EMBRYONIC LETHALITY; MUTANT HUNTINGTIN; GENE HOMOLOG; POLYGLUTAMINE; LOCALIZATION;
D O I
10.1242/dmm.000653
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
A polyglutamine expansion in the huntingtin (HTT) gene causes neurodegeneration in Huntington's disease (HD), but the in vivo function of the native protein (Htt) is largely unknown. Numerous biochemical and in vitro studies have suggested a role for Htt in neuronal development, synaptic function and axonal trafficking. To test these models, we generated a null mutant in the putative Drosophila HTT homolog (htt, hereafter referred to as dhtt) and, surprisingly, found that dhtt mutant animals are viable with no obvious developmental defects. Instead, dhtt is required for maintaining the mobility and long-term survival of adult animals, and for modulating axonal terminal complexity in the adult brain. Furthermore, removing endogenous dhtt significantly accelerates the neurodegenerative phenotype associated with a Drosophila model of polyglutamine Htt toxicity (HD-Q93), providing in vivo evidence that disrupting the normal function of Htt might contribute to HD pathogenesis.
引用
收藏
页码:247 / 266
页数:20
相关论文
共 50 条
  • [41] Huntingtin suppression restores cognitive function in a mouse model of Huntington's disease
    Southwell, Amber L.
    Kordasiewicz, Holly B.
    Langbehn, Douglas
    Skotte, Niels H.
    Parsons, Matthew P.
    Villanueva, Erika B.
    Caron, Nicholas S.
    Ostergaard, Michael E.
    Anderson, Lisa M.
    Xie, Yuanyun
    Dal Cengio, Louisa
    Findlay-Black, Hailey
    Doty, Crystal N.
    Fitsimmons, Bethany
    Swayze, Eric E.
    Seth, Punit P.
    Raymond, Lynn A.
    Bennett, C. Frank
    Hayden, Michael R.
    SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (461)
  • [42] Mutant huntingtin affects p53 function in a context-dependent manner in a cell model of Huntington's disease
    Ellison, Genevieve A.
    Garcia, Loren S.
    Cornett, Jonathan C.
    FASEB JOURNAL, 2018, 32 (01):
  • [43] Falls, Fear of Falling, and Preventive Measures in Huntington's Disease: The Perspectives of Individuals with Huntington's Disease and Caregivers in Long-Term Care
    Kalkers, Kristel
    Schols, Jos M. G. A.
    van Zwet, Erik W.
    Roos, Raymund A. C.
    JOURNAL OF HUNTINGTONS DISEASE, 2021, 10 (04) : 493 - 503
  • [44] Glutamatergic regulation of long-term grafts of fetal lateral ganglionic eminence in a rat model of Huntington's disease
    Hussain, N
    Flumerfelt, BA
    Rajakumar, N
    NEUROBIOLOGY OF DISEASE, 2004, 15 (03) : 648 - 653
  • [45] Huntingtin's WW domain partners in Huntington's disease post-mortem brain fulfill genetic criteria for direct involvement in Huntington's disease pathogenesis
    Passani, LA
    Bedford, MT
    Faber, PW
    McGinnis, KM
    Sharp, AH
    Gusella, JF
    Vonsattel, JP
    MacDonald, ME
    HUMAN MOLECULAR GENETICS, 2000, 9 (14) : 2175 - 2182
  • [46] ARGININE METHYLATION OF HUNTINGTIN IS A NOVEL POST-TRANSLATIONAL MODIFICATION THAT IMPACTS HUNTINGTON'S DISEASE PATHOGENESIS
    Migazzi, Alice
    Tripathy, Debasmita
    Scaramuzzino, Chiara
    Pandey, Udai Bhan
    Saudou, Frederic
    Pennuto, Maria
    Basso, Manuela
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A5 - A6
  • [47] HAP40 is a conserved central regulator of Huntingtin and a potential modulator of Huntington's disease pathogenesis
    Xu, Shiyu
    Li, Gang
    Ye, Xin
    Chen, Dongsheng
    Chen, Zhihua
    Xu, Zhen
    Daniele, Moretti
    Tambone, Sara
    Ceccacci, Alessandra
    Tomei, Licia
    Ye, Lili
    Yu, Yue
    Solbach, Amanda
    Farmer, Stephen M.
    Stimming, Erin Furr
    McAllister, George
    Marchionini, Deanna M.
    Zhang, Sheng
    PLOS GENETICS, 2022, 18 (07):
  • [48] Protective role of Engrailed in a Drosophila model of Huntington's disease
    Mugat, Bruno
    Parmentier, Marie-Laure
    Bonneaud, Nathalie
    Chan, Ho Yin Edwin
    Maschat, Florence
    HUMAN MOLECULAR GENETICS, 2008, 17 (22) : 3601 - 3616
  • [49] Axonal transport defects in a drosophila model of Huntington's disease
    Littleton, JT
    Lee, WM
    JOURNAL OF NEUROCHEMISTRY, 2006, 96 : 143 - 143
  • [50] Altered lipid metabolism in Drosophila model of Huntington's disease
    Aditi, Kumari
    Shakarad, Mallikarjun N.
    Agrawal, Namita
    SCIENTIFIC REPORTS, 2016, 6